Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This study aims to determine the pharmacokinetic profile and the tolerability of iloperidone
in subjects with mild or moderate hepatic impairment comparatively to healthy matched
subjects